Baandrup L, Dehlendorff C, Kjaer SK. One-dose human papillomavirus vaccination and the risk of genital warts: a Danish nationwide population-based study. Clin Infect Dis 2020 (published online Oct 13)
Berenson AB, Hirth JM, Chang M. Prevalence of genital human papillomavirus by age and race/ethnicity among males. Clin Infect Dis 2021 (published online May 13)
Bettampadi D, Sirak BA, Abrahamsen ME, et al. Factors associated with persistence and clearance of high-risk oral HPV among participants in the HPV Infection in Men (HIM) study. Clin Infect Dis 2020 (published online Nov 11)
Bonaldo G, Montanaro N, Vaccheri A, et al. Human papilloma virus vaccination in males: a pharmacovigilance study on the Vaccine Adverse Event Reporting System. Br J Clin Pharmacol 2020 (published online Nov 3)
Brown DR, Joura EA, Yen GP, et al. Systematic literature review of cross-protective effect of HPV vaccines based on data from randomized clinical trials and real-world evidence. Vaccine 2021 (published online Mar 18)
Bukowinski AT, Hall C, Chang RN, et al. Maternal and infant outcomes following exposure to quadrivalent human papillomavirus vaccine during pregnancy. Vaccine 2020 (published online Jul 22)
Chen ST, Huybrechts KF, Bateman BT, et al. Trends in human papillomavirus vaccination in commercially insured children in the United States. Pediatrics 2020 Sep 1;146(3)
Chesson HW, Meites E, Ekwueme DU, et al. Cost-effectiveness of HPV vaccination for adults through age 45 years in the United States: estimates from a simplified transmission model. Vaccine 2020 (published online Oct 27)
Chow EP, Tabrizi SN, Fairley CK, et al. Prevalence of human papillomavirus in young men who have sex with men after the implementation of gender-neutral HPV vaccination: a repeated cross-sectional study. Lancet Infect Dis 2021 (published online May 24)
Closson K, Karim ME, Sadarangani M, et al. Association between human papillomavirus vaccine status and sexually transmitted infection outcomes among females aged 18-35 with a history of sexual activity in the United States: a population survey-based cross-sectional analysis. Vaccine 2020 (published online Nov 22)
Closson K, Karim ME, Sadarangani M, et al. Association between human papillomavirus vaccine status and sexually transmitted infection outcomes among females aged 18-35 with a history of sexual activity in the United States: a population survey-based cross-sectional analysis. Vaccine 2020 (published online Nov 22)
Cornall AM, Saville M, Pyman J, et al. HPV16/18 prevalence in high-grade cervical lesions in an Australian population offered catch-up HPV vaccination. Vaccine 2020 (published online Jul 28)
Coster J, Patel R, Delclos G, et al. Concurrent and concordant oral and genital high-risk human papillomavirus in the U.S.: results from the national Health and Nutrition Examination Survey. J Infect Dis 2020 (published online Aug 17)
Dang JH, Stewart SL, Blumberg DA, et al. Patient and clinician factors associated with uptake of the human papillomavirus (HPV) vaccine among adolescent patients of a primary care network. Vaccine 2021 (published online May 19)
Daniels V, Saxena K, Roberts C, et al. Impact of reduced human papillomavirus vaccination coverage rates due to COVID-19 in the United States: a model based analysis. Vaccine 2021 (published online Apr 6)
Do EK, Rossi B, Miller CA, et al. Area-level variation and human papillomavirus vaccination among adolescents and young adults in the United States: a systematic review. Cancer Epidemiol Biomarkers Prev 2021 Jan
Grewal R, Deeks SL, Hart TA, et al. Human papillomavirus (HPV) vaccine uptake among a community-recruited sample of gay, bisexual, and other men who have sex with men in the three largest cities in Canada from 2017 to 2019. Vaccine 2021 Jun 23;39(28):3756-66
Hoes J, King AJ, Schurink–van't Klooster TM, Berkhof J, et al. Vaccine effectiveness following routine immunization with bivalent HPV vaccine: protection against incident genital HPV infections from a reduced-dosing schedule. J Infect Dis 2021 (published online May 8)
Hoes J, Woestenberg PJ, Bongaards JA, et al. Population impact of girls-only HPV16/18 vaccination in the Netherlands: cross-protective and second-order herd effects. Clin Infect Dis 2020 (published online Nov 28)
Hviid A, Thorsen NM Valentiner-Branth P, et al. Association between quadrivalent human papillomavirus vaccination and selected syndromes with autonomic dysfunction in Danish females: population based, self-controlled, case series analysis. BMJ 2020 Sep 2;370:m2930
Kelly MK, Grundmeier RW, Stephens-Shields AJ, et al. Missed opportunities for human papillomavirus vaccination at office visits during which influenza vaccine was administered: an AAP pediatric research in office settings (PROS) national primary care research network study. Vaccine 2020 Jul 14;38(33):5105-8
